Ludmila Perelygina David Buchbinder Morna J Dorsey Marc Eloit Fabian Hauck Timo Hautala Despina Moshous Ignacio Uriarte Elena Deripapa Joseph Icenogle Kathleen E Sullivan
10.1007/s10875-019-0589-0
J Clin Immunol
2019 Jan;39(1):112-117.
granulomas mmr chronic inflammation nitazoxanide vaccine
author_manuscript
https://pubmed.ncbi.nlm.nih.gov/30680653/
Granuloma / drug therapy Immunologic Deficiency Syndromes / virology Rubella / drug therapy Rubella virus / drug effects Thiazoles / therapeutic use
Granuloma / drug therapy Immunologic Deficiency Syndromes / virology Rubella / drug therapy Rubella virus / drug effects Thiazoles / therapeutic use Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Adolescent Child Child, Preschool Female Granuloma / virology Humans Infant Male Nitro Compounds Retrospective Studies Rubella / virology T-Lymphocytes / drug effects T-Lymphocytes / virology Vaccination / methods Nitro Compounds Thiazoles nitazoxanide
PMC6383808
30680653
Outcomes for Nitazoxanide Treatment in a Case Series of Patients with Primary Immunodeficiencies and Rubella Virus-Associated Granuloma
2019